Valeant Intends to Move B+L's HQ to NJ As Part of Its $8.7B Acquisition

LAVAL, Quebec—Valeant Pharmaceuticals (NYSE: VRX, TSX: VRX) said that it will eliminate as much as 15 percent of its workforce and move Bausch + Lomb's headquarters to New Jersey as part of its $8.7 billion acquisition of the company.   In a letter to its own and Bausch + Lomb workers, published in an SEC filing dated July 29, 2013, Valeant said that after the deal closes, it will eliminate between 10 percent and 15 percent of positions companywide. That works out to between 1,850 and 2,775 people and is expected to include both Valeant and Bausch + Lomb workers. Reductions are not expected in the Bausch + Lomb North American or worldwide field forces.   See more